First Person to Tell COVID-19 Vaccine Explained


Jennifer Haller, 44, the first person to try the vaccine against the new type of coronavirus disease COVID-19 in the United States (USA), told what happened. Haller said he had no complaints other than pain on his arm on the second day.

The new type of coronavirus (COVID-19) epidemic, which is thought to have emerged from a live animal market in Wuhan city with 11 million population, continues to be one of the biggest problems facing humanity. While the balance sheet continues to get worse day by day, the number of approved cases worldwide has placed 2 million stairs. The number of casualties rose by 5,471 in the last 24 hours to 119,686.

Scientists around the world are working to find an effective vaccine against COVID-19. Despite the important clues they have obtained, the researchers who have removed the genome structure of the virus and even detected its weak point have not yet been able to find the cure for the fatal infection.

Jennifer Haller, 44, was the first person to try the vaccine against coronavirus.
In our previous report, we shared with you that Kaiser Permanente, a US-based non-profit health organization, is looking for volunteer subjects for the experiments of vaccines to be developed for COVID-19 in Seattle. Jennifer Haller, 44, the first person to try that vaccine, told her experiences in the British newspaper The Telegraph.

Stating that he sees volunteers looking for vaccines to be developed against coronavirus on Facebook, Haller stated that he applied for a volunteer drug test based on the idea that “I should also have a contribution”. Stating that he received some reactions from his close circle, especially his wife and children, after his decision, Haller said, “Yes, there are many risks, but I am a very positive person and I did my best to ignore the risks.”

See Also
How does bioinformatics work in ranking COVID?

Haller, the mother of two, says she is proud to contribute to the vaccine study
The 44-year-old American woman, who stated that she had a little fever on the first day of the vaccination and felt a slight pain on the second day, stated that she had no other complaints. Stating that the society should help scientific research on COVID-19, Haller said that he has complete confidence that the vaccine will be found.

Within the scope of the study, 45 healthy people in the 18-55 age group, who want to volunteer drug testing in the clinical setting, are randomly divided into three groups and each is given a different dose of the experimental vaccine. Participants will earn a total of $ 1,100 if they are vaccinated 11 times over a 14-month period.

According to the World Health Organization (WHO), there are currently 70 different vaccine studies in different parts of the world.
According to the World Health Organization (WHO), there are 70 different COVID-19 vaccines currently being developed worldwide. Sarah Gilbert, professor of vaccine science from Oxford University, said in a statement the other day, that the vaccine developed against coronavirus will be available in September with a probability of 80 percent.


Please enter your comment!
Please enter your name here